[
  {
    "ts": null,
    "headline": "Bristol CEO: Pharma Tariffs Must Not Jeopardize Medicine Supplies",
    "summary": "Bristol-Myers Squibb Chief Executive Chris Boerner said at The Wall Street Journal's Future of Everything festival on Thursday that potential tariffs targeting the drug industry from the Trump administration must not create supply constraints.  Bristol and other drugmakers are bracing for tariffs targeting pharmaceuticals shipped to the U.S. from other countries.  The administration has been conducting an investigation into such levies, and analysts expect them to be announced in coming weeks.",
    "url": "https://finnhub.io/api/news?id=ce5a55585dfdbf3c2714504f6f800aa213ca160c90a95f16c17c95705fe26152",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748543727,
      "headline": "Bristol CEO: Pharma Tariffs Must Not Jeopardize Medicine Supplies",
      "id": 134863596,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Chief Executive Chris Boerner said at The Wall Street Journal's Future of Everything festival on Thursday that potential tariffs targeting the drug industry from the Trump administration must not create supply constraints.  Bristol and other drugmakers are bracing for tariffs targeting pharmaceuticals shipped to the U.S. from other countries.  The administration has been conducting an investigation into such levies, and analysts expect them to be announced in coming weeks.",
      "url": "https://finnhub.io/api/news?id=ce5a55585dfdbf3c2714504f6f800aa213ca160c90a95f16c17c95705fe26152"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=85ad151a4f1497339e9c7eb55ebb0b52d79bb71888bdcdb9ec9e71494be759b4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748536800,
      "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "id": 134901105,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=85ad151a4f1497339e9c7eb55ebb0b52d79bb71888bdcdb9ec9e71494be759b4"
    }
  },
  {
    "ts": null,
    "headline": "BMY's Opdivo SC Gets EU Nod for Multiple Solid Tumor Indications",
    "summary": "Bristol Myers' Opdivo SC wins EU approval as the first PD-1 inhibitor for subcutaneous use across multiple solid tumor indications.",
    "url": "https://finnhub.io/api/news?id=57d485f767d66340f5629446022b9c1a94aa80bcad0f09a369a077ffb8ff1d56",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748533440,
      "headline": "BMY's Opdivo SC Gets EU Nod for Multiple Solid Tumor Indications",
      "id": 134868075,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers' Opdivo SC wins EU approval as the first PD-1 inhibitor for subcutaneous use across multiple solid tumor indications.",
      "url": "https://finnhub.io/api/news?id=57d485f767d66340f5629446022b9c1a94aa80bcad0f09a369a077ffb8ff1d56"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Loses 20.7% in 3 Months: Buy, Sell or Hold the Stock?",
    "summary": "BMY slides 20.7% in 3 months despite strong Q1 and raised outlook, as generic pressure and pipeline setbacks weigh on investor sentiment.",
    "url": "https://finnhub.io/api/news?id=8c3f49a540d6c927c29edb18ac287421f5c721f0289f362688b9da61a1b60af3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748524680,
      "headline": "Bristol Myers Loses 20.7% in 3 Months: Buy, Sell or Hold the Stock?",
      "id": 134812511,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BMY slides 20.7% in 3 months despite strong Q1 and raised outlook, as generic pressure and pipeline setbacks weigh on investor sentiment.",
      "url": "https://finnhub.io/api/news?id=8c3f49a540d6c927c29edb18ac287421f5c721f0289f362688b9da61a1b60af3"
    }
  },
  {
    "ts": null,
    "headline": "EC approves BMS’ nivolumab SC formulation for solid tumours",
    "summary": "The decision was influenced by the Phase III CheckMate -67T trial outcomes.",
    "url": "https://finnhub.io/api/news?id=d94ad61f9887158715130c5fc2105533a2a67d45f3b35b7b81d2a7e98c573710",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748509206,
      "headline": "EC approves BMS’ nivolumab SC formulation for solid tumours",
      "id": 134812514,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The decision was influenced by the Phase III CheckMate -67T trial outcomes.",
      "url": "https://finnhub.io/api/news?id=d94ad61f9887158715130c5fc2105533a2a67d45f3b35b7b81d2a7e98c573710"
    }
  },
  {
    "ts": null,
    "headline": "1 S&P 500 Stock for Long-Term Investors and 2 to Brush Off",
    "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
    "url": "https://finnhub.io/api/news?id=2390a73a5cf306d0428b06f1f74d2c64886a9c55bed7c8c1b2aa4c1182e9343d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748493348,
      "headline": "1 S&P 500 Stock for Long-Term Investors and 2 to Brush Off",
      "id": 134812201,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
      "url": "https://finnhub.io/api/news?id=2390a73a5cf306d0428b06f1f74d2c64886a9c55bed7c8c1b2aa4c1182e9343d"
    }
  }
]